Biohaven is powering ahead with its bold ambition to sharply reduce R&D spending—even as analysts warn the company will need to be even stricter with its expenditures. | Biohaven is powering ahead ...
Armor Health donated $50,000 to Sheriff Carmine Marceno’s PAC while holding the Lee County jail healthcare contract.
A study found that fecal transplants from older female mice improved ovarian function and fertility in younger mice. Findings ...
Virtual apertures let researchers isolate and solve atomic structures from individual nanocrystals embedded in dense clusters, providing valuable new data for energy and pharmaceutical applications.
Dan Bird MBE, Field Chief Technology Officer (EMEA) at Horizon3.ai, highlights why cyber resilience must move beyond policy and toward continuous operational rehearsal — reinforcing insights from ...
Next week, researchers, clinicians, industry leaders, and families will gather at the 2026 MDA Clinical & Scientific Conference, hosted by the Muscular Dystrophy Association (MDA), to discuss the ...
Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsPatrick Soon-Shiong - Founder, Executive Chairman and ...
CALGARY, AB, March 3, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, ...
Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...
In pharmaceutical, biotechnology, and high-purity industrial settings, filter performance directly affects product quality and ...
With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter,” early stage biotechs are rewriting their financing strategies around ...
ShunzymeX addresses inherent challenges in traditional microbial downstream purification due to microbial-expressed protein diversity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results